Search results
17 mar 2008 · The goals of the present article are to provide a critical review of the literature on cocaine-associated chest pain and myocardial infarction (MI) and to give guidance for diagnostic and therapeutic interventions.
15 gru 2018 · The purpose of this systematic review and meta-analysis is to investigate the evidence pertaining to the use of beta-blockers in the setting of acute cocaine-related chest pain and its implication on clinical outcomes.
1 kwi 2013 · Review of the Data Diagnostic evaluation. Given potential differences in treatment regimens, it is imperative to differentiate patients who present with CACP from those whose chest pain is not associated with cocaine either by direct questioning or by screening of urine for cocaine metabolites.
17 mar 2008 · Hollander JE, Hoffman RS, Gennis P, Fairweather P, DiSano MJ, Schumb DA, Feldman JA, Fish SS, Dyer S, Wax P, Whelan C, Schwartzwald E. Nitroglycerin in the treatment of cocaine associated chest pain–clinical safety and efficacy.
We aim to update the reader on more recent, albeit small, studies on the emergency department evaluation and clinical and pharmacologic management of cocaine-associated chest pain. Finally, we summarize recent guidelines and review an algorithm based on the current best evidence.
3 lis 2020 · Cocaine-related vasoconstriction can still cause acute MI hours or as many as 4 days later (rarely) CLINICAL FEATURES. Chest pain is not reliably present in patients with cocaine-associated MI. only 44% of patients with cocaine-associated MI had chest pain (Hollander and Hoffman, J Emerg Med 1992)
However, β-blocker therapy in patients with cocaine-associated chest pain (CACP) continues to be an area of debate due to the potential risk of unopposed α-adrenergic stimulation and coronary vasospasm.
